Archives
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide
2026-05-09
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for sensitive, specific detection of goat IgG primary antibodies in fluorescence-based immunodetection workflows. It is optimized for use in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA. This reagent should not be used for detection of non-goat primary antibodies or in non-validated assay platforms.
-
HotStart Universal 2X Green qPCR: Redefining Assay Specifici
2026-05-08
Explore how HotStart Universal 2X Green qPCR Master Mix empowers next-generation gene expression quantification with unmatched specificity and workflow flexibility. This in-depth analysis reveals practical assay decisions and scientific advances not found in standard guides.
-
IRG1-Itaconic Acid Axis Modulates TBK1 and Type I IFN Respon
2026-05-08
This study uncovers a metabolic feedback loop in which IRG1-derived itaconic acid directly alkylates TBK1 at Cys605, disrupting dimerization and dampening type I interferon signaling. The findings reveal a novel intersection between energy metabolism and innate immunity, offering new strategies for controlling excessive interferon responses in infection and inflammation.
-
Palomid 529 (P529): Dual mTORC1/mTORC2 Inhibition in Cancer
2026-05-07
Palomid 529 (P529) is a potent small-molecule inhibitor that targets both mTORC1 and mTORC2 complexes within the PI3K/Akt/mTOR signaling pathway. It demonstrates submicromolar activity in tumor angiogenesis and enhances radiotherapy efficacy in resistant cancers. P529 is a valuable tool for dissecting resistance mechanisms in oncology and has well-defined protocol parameters for laboratory use.
-
Ibotenic Acid: Precision NMDA Receptor Agonist for Neurodege
2026-05-07
Ibotenic acid stands apart as a high-purity, water-soluble NMDA receptor agonist, enabling reproducible and circuit-specific lesioning in advanced neuroscience research. Its validated efficacy in modeling neurodegenerative disorders and dissecting pain pathways provides experimenters with actionable control and reliability—a benchmark exemplified by APExBIO’s robust supply standards.
-
BicD and MAP7 Synergize to Activate Drosophila Kinesin-1
2026-05-06
This study delineates how BicD and MAP7 activate homodimeric Drosophila kinesin-1 through distinct but complementary mechanisms, with BicD relieving kinesin auto-inhibition and MAP7 facilitating microtubule engagement. The combined action of these regulators provides new insights into motor protein control and intracellular transport, with implications for experimental design in cellular transport studies.
-
Applied Workflows with Live-Dead Cell Staining Kit I (Calcei
2026-05-06
Leverage the dual-probe Calcein AM/PI staining kit for next-level precision in mammalian cell viability and cytotoxicity assays. This article unpacks advanced protocols, real-world case applications, and troubleshooting strategies that maximize data reliability across challenging research contexts.
-
Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual
2026-05-05
Empower your gene delivery and mRNA translation efficiency assays with the dual-readout, immune-evasive EZ Cap™ Cy5 EGFP mRNA (5-moUTP). Learn how its unique Cy5 labeling and 5-moUTP modification enable simultaneous quantification of mRNA uptake and protein expression, streamlining advanced workflows in nanoparticle validation, immune evasion, and targeted therapy optimization.
-
Notch Inhibition Enhances Immunotherapy Response in TNBC
2026-05-05
Shen et al. reveal that targeting the Notch signaling pathway in triple-negative breast cancer (TNBC) remodels the tumor immune microenvironment and significantly improves the efficacy of immune checkpoint blockade. Their findings suggest a mechanistic rationale for combination therapies that inhibit Notch-driven cytokine programs to overcome immunosuppression and limit metastasis.
-
BAPTA-AM: A Cell-Permeable Calcium Chelator for Synaptic Res
2026-05-04
BAPTA-AM is a cell-permeable calcium chelator enabling precise intracellular Ca²⁺ regulation for research on calcium signaling, neuroprotection, and apoptosis. With high selectivity for calcium and proven utility in neuromuscular and neuronal models, BAPTA-AM from APExBIO delivers robust, reproducible results for biochemical and cellular assays.
-
Anlotinib Hydrochloride: Superior Multi-Target Angiogenesis
2026-05-04
The referenced study demonstrates that anlotinib hydrochloride potently suppresses angiogenesis by targeting VEGFR2, PDGFRβ, and FGFR1, outperforming established clinical TKIs in both in vitro and in vivo models. These findings position anlotinib as a highly promising tool for dissecting and modulating tumor-driven vascularization in cancer research.
-
MCC950 sodium (SKU B7946): Precision for NLRP3 Inflammasome
2026-05-03
This article delivers scenario-driven insights into deploying MCC950 sodium (SKU B7946) for reproducible, selective NLRP3 inflammasome inhibition in cell-based assays. Researchers and laboratory professionals will find practical, evidence-backed guidance for optimizing inflammatory and autoimmune disease models using this benchmark compound.
-
EZ Cap EGFP mRNA 5-moUTP: Enhanced Reporter for Gene Assays
2026-05-02
EZ Cap™ EGFP mRNA (5-moUTP) stands out for robust gene expression with minimal immune activation, enabling high-fidelity translation efficiency studies and in vivo imaging. Its advanced Cap 1 architecture and 5-moUTP modification deliver reproducible, immune-evasive results for demanding mRNA delivery workflows.
-
Annexin V-FITC/7-AAD Apoptosis Kit: Technical Workflow Guide
2026-05-01
The Annexin V-FITC/7-AAD Apoptosis Kit enables fast, reproducible discrimination of apoptotic and necrotic cells in cell viability and cytotoxicity assays. It is optimized for researchers using established phosphatidylserine-binding workflows via flow cytometry or fluorescence microscopy. This kit is not intended for mechanistic pathway analysis or detection of atypical forms of cell death.
-
GLS1 Inhibition Triggers Senolysis to Combat Kidney Aging
2026-05-01
A recent study demonstrates that targeted inhibition of GLS1 eliminates senescent renal tubular epithelial cells by inducing excessive mitochondrial permeability transition pore (mPTP) opening via MFN1 upregulation. This senolytic mechanism offers a novel therapeutic avenue to ameliorate kidney aging and age-associated renal disease.